Bausch & Lomb (NYSE: BOL), an eye health company based in Rochester, N.Y., has announced the preliminary settlement of the securities class action pending against the company in the W.D.N.Y. The suit was originally filed in December 2001 and claims that the value of Bausch’s stock “was artificially inflated by alleged false and misleading statements about expected financial results for the fiscal year 2000.”
The settlement is for $12.5 million and will be paid by Bausch’s insurance carrier.
The 10b-5 Daily 